Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
Dördelmann M, Schrappe M, Reiter A, Zimmermann M, Graf N, Schott G, Lampert F, Harbott J, Niemeyer C, Ritter J, Dörffel W, Nessler G, Kühl J, Riehm H. Dördelmann M, et al. Among authors: dorffel w. Leukemia. 1998 May;12(5):645-51. doi: 10.1038/sj.leu.2400989. Leukemia. 1998. PMID: 9593260
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, Dörffel W, Zimmermann M, Mann G, Gadner H, Parwaresch R, Riehm H, Reiter A. Seidemann K, et al. Among authors: dorffel w. Blood. 2001 Jun 15;97(12):3699-706. doi: 10.1182/blood.v97.12.3699. Blood. 2001. PMID: 11389005 Free article. Clinical Trial.
[Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
Schrappe M, Reiter A, Sauter S, Ludwig WD, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E, et al. Schrappe M, et al. Among authors: dorffel w. Klin Padiatr. 1994 Jul-Aug;206(4):208-21. doi: 10.1055/s-2008-1046607. Klin Padiatr. 1994. PMID: 7526027 Clinical Trial. German.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M; German-Austrian-Swiss ALL-BFM Study Group. Möricke A, et al. Blood. 2008 May 1;111(9):4477-89. doi: 10.1182/blood-2007-09-112920. Epub 2008 Feb 19. Blood. 2008. PMID: 18285545 Free article. Clinical Trial.
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G, Pötter R, Brämswig J, Wagner W, Prott FJ, Dörffel W, Körholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, Thiemann M, Schwarze EW. Schellong G, et al. Among authors: dorffel w. J Clin Oncol. 1999 Dec;17(12):3736-44. doi: 10.1200/JCO.1999.17.12.3736. J Clin Oncol. 1999. PMID: 10577845 Clinical Trial.
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment.
Müller HJ, Beier R, Löning L, Blütters-Sawatzki R, Dörffel W, Maass E, Müller-Weihrich S, Scheel-Walter HG, Scherer F, Stahnke K, Schrappe M, Horn A, Lümkemann K, Boos J. Müller HJ, et al. Among authors: dorffel w. Br J Haematol. 2001 Sep;114(4):794-9. doi: 10.1046/j.1365-2141.2001.03009.x. Br J Haematol. 2001. PMID: 11564065 Free article.
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years].
Dörffel W, Albrecht M, Lüders H, Marciniak H, Parwaresch R, Schwarze EW, Trauzeddel R, Havers W, Henze G, Janka-Schaub G, Mann G, Niemeyer C, Pötter R, Schellong G, Selle B, Treuner J, Rühl U. Dörffel W, et al. Klin Padiatr. 1998 Jul-Aug;210(4):212-9. doi: 10.1055/s-2008-1043881. Klin Padiatr. 1998. PMID: 9743955 Clinical Trial. German.
92 results